AB Molecular Ltd is a joint venture company between AB Scientific Ltd and TCS Biosciences Ltd and is the exclusive distributor in the UK of GenMark Dx.
Early identification of sepsis is critical to ensure the best possible patient outcome. GenMark Dx has developed ePlex, a rapid system that requires minimal hands-on time for the operator. The blood culture Identification panels (BCID) provides broad coverage of organisms that cause sepsis, aiding timely critical treatment decisions.
ePlex BCID enables physicians to rapidly identify clinically relevant bloodstream infections and their resistance genes while ruling out blood culture contamination, enabling faster treatment decisions.
Tel: 020 8396 0420